000294808 001__ 294808
000294808 005__ 20250309015459.0
000294808 0247_ $$2doi$$a10.1111/cas.16414
000294808 0247_ $$2pmid$$apmid:39624886
000294808 0247_ $$2ISSN$$a1344-6428
000294808 0247_ $$2ISSN$$a0910-5050
000294808 0247_ $$2ISSN$$a1347-9032
000294808 0247_ $$2ISSN$$a1349-7006
000294808 0247_ $$2ISSN$$a1876-4673
000294808 0247_ $$2altmetric$$aaltmetric:171873654
000294808 037__ $$aDKFZ-2024-02520
000294808 041__ $$aEnglish
000294808 082__ $$a610
000294808 1001_ $$0P:(DE-He78)ad2dff19f16208697af82eaa31fa9d60$$aZhao, Zitong$$b0$$eFirst author$$udkfz
000294808 245__ $$aSmoking-independent DNA methylation markers for lung cancer risk: External validation in a large population-based cohort study.
000294808 260__ $$aTokyo$$bAssoc.$$c2025
000294808 3367_ $$2DRIVER$$aarticle
000294808 3367_ $$2DataCite$$aOutput Types/Journal article
000294808 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1741098234_5644
000294808 3367_ $$2BibTeX$$aARTICLE
000294808 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000294808 3367_ $$00$$2EndNote$$aJournal Article
000294808 500__ $$a#EA:C070#LA:C070#LA:C120# / 2025 Mar;116(3):775-782
000294808 520__ $$aSmoking-associated epigenetic changes have been linked to lung cancer (LC) risk; however, the role of epigenetic alterations independent of smoking is yet to be fully understood. This study aimed to validate 16 previously reported CpG sites that are independent of smoking yet associated with LC risk within a population-based prospective cohort. Using the Infinium Methylation EPIC BeadChip kit or the Infinium HumanMethylation450K BeadChip Assay, DNA methylation (DNAm) in whole blood was assessed in four subsets (n = 736, 1027, 997, and 312) of a population-based cohort from Germany. The DNAm levels of the 16 smoking-independent CpG sites were analyzed. Hazard ratios (HRs) and their 95% confidence intervals (95% CIs) were calculated to assess associations of DNAm at the 16 CpG sites with LC risk, adjusting for multiple covariates, including smoking habits and a smoking-associated DNAm score. Over 17 years of follow-up, a total of 199 LCs were observed. Among the 16 CpGs, cg02211449 showed a negative association with LC risk (HR [95% CI] per SD increase, = 0.70 [0.63-0.78]), while cg11385536 (1.04 [1.01-1.07]), cg09736286 (1.64 [1.10-2.44]), cg19907023 (1.64 [1.01-2.66]), and cg22032485 (1.52 [1.04-2.21]) displayed positive associations with LC risk. Five of the 16 suggested smoking-independent CpGs could be externally validated as predictors of LC risk. Further research should address their potential contribution to enhanced LC risk stratification.
000294808 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000294808 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000294808 650_7 $$2Other$$aDNA methylation
000294808 650_7 $$2Other$$aepigenome‐wide association study (EWAS)
000294808 650_7 $$2Other$$aexternal validation
000294808 650_7 $$2Other$$alung cancer risk
000294808 7001_ $$0P:(DE-He78)ac7aed57f26354e8a484b5d257f7bada$$aBhardwaj, Megha$$b1$$udkfz
000294808 7001_ $$0P:(DE-He78)79862c68074f8d78156f06f6e3c9801c$$aFan, Ziwen$$b2$$udkfz
000294808 7001_ $$0P:(DE-He78)a92f91afa83da73641a4f3abec1d3c6d$$aLi, Xianzhe$$b3$$udkfz
000294808 7001_ $$0P:(DE-He78)01ef71f71b01a3ec3b698653fd43fe86$$aSchrotz-King, Petra$$b4$$udkfz
000294808 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b5$$eLast author$$udkfz
000294808 773__ $$0PERI:(DE-600)2115647-5$$a10.1111/cas.16414$$gp. cas.16414$$n3$$p775-782$$tCancer science$$v116$$x1344-6428$$y2025
000294808 909CO $$ooai:inrepo02.dkfz.de:294808$$pVDB
000294808 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)ad2dff19f16208697af82eaa31fa9d60$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000294808 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)ac7aed57f26354e8a484b5d257f7bada$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000294808 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)79862c68074f8d78156f06f6e3c9801c$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000294808 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a92f91afa83da73641a4f3abec1d3c6d$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000294808 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)01ef71f71b01a3ec3b698653fd43fe86$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000294808 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000294808 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000294808 9141_ $$y2024
000294808 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-25
000294808 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-25
000294808 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-25
000294808 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCER SCI : 2022$$d2023-10-25
000294808 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-25
000294808 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-25
000294808 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-25
000294808 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-25
000294808 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-25
000294808 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-10-25
000294808 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-25
000294808 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2022-10-23T21:03:42Z
000294808 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2022-10-23T21:03:42Z
000294808 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2022-10-23T21:03:42Z
000294808 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCANCER SCI : 2022$$d2023-10-25
000294808 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2023-10-25
000294808 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2023-10-25
000294808 9202_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000294808 9202_ $$0I:(DE-He78)C120-20160331$$kC120$$lPrimäre Krebsprävention$$x1
000294808 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000294808 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x1
000294808 9201_ $$0I:(DE-He78)C120-20160331$$kC120$$lPrimäre Krebsprävention$$x2
000294808 9200_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000294808 980__ $$ajournal
000294808 980__ $$aVDB
000294808 980__ $$aI:(DE-He78)C070-20160331
000294808 980__ $$aI:(DE-He78)HD01-20160331
000294808 980__ $$aI:(DE-He78)C120-20160331
000294808 980__ $$aUNRESTRICTED